Feasible and effective cell models for hepatitis B virus (HBV) infection are required for investigating the complete lifecycle of this virus, including the early steps of viral entry. Resistance to dimethyl sulfoxide/polyethylene glycol (DMSO/PEG), hNTCP expression, and a differentiated state are the limiting factors for successful HBV infection models. In the present study, we used a hepatoma cell line (Huh7D hNTCP ) to overcome these limiting factors so that it exhibits excellent susceptibility to HBV infection. To achieve this goal, different hepatoma cell lines were tested with 2.5% DMSO / 4% PEG8000, and one resistant cell line (Huh7D) was used to construct a stable hNTCP-expressing cell line (Huh7D hNTCP ) using a recombinant lentivirus system. Then, the morphological characteristics and differentiation molecular markers of Huh7D hNTCP cells with or without DMSO treatment were characterized. Finally, the susceptibility of Huh7D hNTCP cells to HBV infection was assessed. Our results showed that Huh7D cells were resistant to 2.5% DMSO / 4% PEG8000, whereas the others were not. Huh7D hNTCP cells were established to express a high level of hNTCP compared to liver extracts, and Huh7D hNTCP cells rapidly transformed into a non-dividing, well-differentiated polarized phenotype under DMSO treatment. Huh7D hNTCP cells fully supported the entire lifecycle of HBV infection. This cell culture system will be useful for the analysis of host-virus interactions, which should facilitate the discovery of antiviral drugs and vaccines.
INTRODUCTION
Hepatitis B virus (HBV) infection causes a wide spectrum of clinical manifestations ranging from an asymptomatic carrier state to acute or chronic hepatitis, with progression to liver cirrhosis and hepatocellular carcinoma. Currently available interferon and nucleos(t)ide analogues (NA) cannot effectively eradicate the virus. A better understanding of the HBV life cycle is necessary to design more effective therapeutic strategies.
Feasible and effective cell models for HBV infection are required for investigating the complete lifecycle of this virus, including the early steps of the viral cycle. Currently, primary human hepatocytes (PHHs) (Lempp et al., 2017; Ni and Urban, 2017; Shimura et al., 2017) , HepaRG cells (Gripon et al., 2002; Schulze et al., 2012) , and primary tupia hepatocytes (PTHs) (Kock et al., 2001; Ren and Nassal, 2001 ) are the main cell models used to study the early steps of HBV infection. PHHs, the natural host of HBV, are regarded as the ideal cellular model for HBV infection. However, poor accessibility, lot-to-lot variation, and rapid loss of susceptibility limit the applications of PHHs. HepaRG cells, a human liver progenitor cell line, retain the differential ability to polarize into hepatocyte-like cells and become susceptible to HBV infection following induction with dimethyl sulfoxide (DMSO) and hydrocortisone (Gripon et al., 2002) . The drawbacks of HepaRG cells, such as low efficiency of infection, a time-consuming process for the induction of PHH-like polarization, and patent protection, prevent their wide utilization. PTHs, an alternative for PHHs, can be accessed more easily, and more homogeneous populations can be obtained. However, the addition of DMSO and polyethylene glycol 8000 (PEG8000) during the infection of PTHs does not significantly promote the infectivity of HBV (Weizsäcker and Roggendorf, 2005) . In addition, human serum competes with HBV particles for binding to the cell membrane (Kock et al., 2001 ), leading to a reduced experimental confidence level. Novel HBV infection models are thus urgently needed.
In 2012, a functional receptor for HBV/HDV infection, Na+/taurocholate cotransporting polypeptide (NTCP) (Yan et al., 2012) , was identified. A 3.6-fold induction of hNTCP mRNA was observed in HepaRG cells differentiated by DMSO exposure, whereas knockdown of hNTCP was shown to completely block HBV and HDV infection in HepaRG cells, suggesting the essential role of hNTCP in HBV/HDV entry (Ni et al., 2014) . A HepG2 cell line stably expressing hNTCP (HepG2 hNTCP ) was reported to support HBV infection (Yan et al., 2012; Ni et al., 2014) .
As HBV naturally infects and replicates in highly differentiated and non-dividing human hepatocytes, cells in a non-dividing, well-differentiated state may be superior to poorly differentiated and dividing hepatoma cells for establishing HBV infection (Sainz and Chisari, 2006; Tian et al., 2016) . DMSO enhances cell differentiation and HBV transcription and replication, and it is normally added to the culture media of HBV-infected PHHs and HepaRG cells (Gripon et al., 1988; Gripon et al., 2002; Schulze-Bergkamen et al., 2003) . However, different cells exhibit quite different tolerances to DMSO. Therefore, DMSO and a differentiated state are regarded as limiting factors for establishing feasible and effective HBV infection models. In addition, resistance to 4% PEG8000 and hNTCP expression level are also limiting factors for effective HBV infection (Gripon et al., 1993; Yan et al., 2012) .
Huh7 is a hepatoma cell line originally obtained from a 57-year-old Japanese male in 1982 who was suffering from liver tumor (Nakabayashi et al., 1982) . After induction by 1% DMSO, Huh7 can transform into a non-dividing, well-differentiated phenotype (Sainz and Chisari, 2006) , which may be a feasible platform to establish productive HBV infection. In the present study, we established an hNTCP-expressing Huh7 cell line (Huh7D hNTCP ) that was tolerant to 2.5% DMSO/4% PEG8000, stably expressed a high level of hNTCP, and rapidly transformed into a non-dividing, well differentiated phenotype following DMSO induction. Under these conditions, Huh7D hNTCP cells possessed an optimized susceptibility to HBV infection.
MATERIALS AND METHODS

Human materials and ethical statement
Embryonic liver tissues were kindly provided by Zhongnan Hospital of Wuhan University with informed written consent from all participating family members. Ethical approval for the study was granted by the institutional bioethics committee of Wuhan Institute of Virology, Chinese Academy of Sciences (approval number WIVH 24201101).
Vector construction and lentivirus production
The lentiviral vectors (pWPI) and packaging plasmids (pCMV-dR8.91 and pMD.2G) were obtained from Addgene (http://www.addgene.org) and have been described elsewhere (Wiznerowicz and Trono, 2003) . To construct pWPI-Puro, the puromycin-resistance gene was inserted to replace GFP. hNTCP (with the same coding sequence as previously reported) (Yan et al., 2012) was inserted into pWPI-Puro. Recombinant lentiviruses were produced as previously described (Wang et al., 2013) . After 48 h, the culture medium was collected, and centrifuged to remove debris at 1000 × g for 10 min, followed by filtration through 0.45-μm cellulose acetate filters (Millipore, Billerica, Massachusetts, USA). Then, the filtered medium was centrifuged using Ultracel-100K centrifugal filters (Millipore). Finally, the concentrated lentivirus was stored at -80 °C ready for experiments.
Cell culture and cell establishment Huh7D hNTCP cells were established by adding recombinant lentivirus to the culture medium in the presence of 6 μg/mL polybrene (Sigma, Shanghai, China). The medium was refreshed 12 h later, and 5~10 μg/mL puromycin (InvivoGen, San Diego, CA, USA) was added to the cells 48 h later to screen for positive cells.
Cell lines (293T, HepG2, Huh7, Huh7D hNTCP , and HepG2 hNTCP ) were maintained in Dulbecco's modified Eagle's medium (DMEM, Gibco, Grand Island, USA) supplemented with 10% fetal bovine serum (Gibco), 100 U/mL penicillin, and 100 μg/mL streptomycin. Huh7D hNTCP cells were induced by 2.5% DMSO (Inducing medium: DMEM supplemented with 5% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin) for 24 h before HBV infection, whereas HepG2 hNTCP cells were maintained in PMM (2.5% DMSO) for 24 h before HBV infection, as described elsewhere (Yan et al., 2012) .
HBV virus preparation and HBV/HCV infection HBV infectious particles were prepared from HepAD38 cells as previously described (Schulze et al., 2010) . Concentrated HBV stocks diluted in PMM and supplemented with 4% (w/v) PEG8000 were added directly to susceptible cells. After a 24-h incubation, the cells were washed extensively three times with PBS, and the media were refreshed. Huh7D hNTCP cells were maintained in inducing medium, and HepG2 hNTCP cells were maintained in PMM (2.5% DMSO). For the HBV binding and uptake assay, approximately 2 × 10 6 Huh7D hNTCP or HepG2 hNTCP cells in each well of a 6-well plate were incubated with HBV in the presence of 4% PEG8000 at 4 °C for 24 h (HBV binding only), at 37 °C for 24 h (binding and uptake), or at 37 °C for 24 h but digested with trypsin for 10 min followed by washing twice with 1×PBS to remove bound HBV particles (uptake only). HBV DNA was extracted using a method described by Hirt (Hirt, 1967) . Myrcludex B, the analogue of myr-preS1 2-47 , was synthesized by GL Biochem Company (Shanghai, China) and used to specifically block HBV infection.
HCV J399EM (genotype 2a) was prepared and infected as previously reported (Han et al., 2009; Cao H. et al., 2014a) . The HCV virion was added to susceptible cell lines at a multiplicity of infection (MOI) of 1, and chimeric HCV-GFP was recorded with a fluorescence microscope.
Enzyme-linked immunosorbent assay
The culture media were collected at the indicated time points. The level of HBsAg or HBeAg was detected by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (KHB, Shanghai, China). Each sample was measured in triplicate utilizing an Epoch Microplate Spectrophotometer (Bio-Tek, Winooski, USA), and the values are presented as the mean of OD 450 -OD 630 ± standard deviation. The cut-off value was calculated according to manufacturer's instructions.
RNA extraction and reverse transcription for real-time PCR
Total RNA was extracted from the cells, using TRIzol Reagent (Invitrogen, Carlsbad, USA) according to the manufacturer's protocol. Real-time PCR was performed on an ABI QuantSudio 6 Flex device, using a QuantiTech SYBR Green RT-PCR Kit (Qiagen, Hilden, Germany).
β-Actin was served as the internal control for sample normalization. The relative mRNAs level was calculated using the △△C T method. All samples were measured in triplicate, and all experiments were repeated independently three times. The primers used for real-time PCR are listed in Table 1 .
Western blot
Western blot was performed as previously described (Zhou et al., 2014b) . The primary antibodies used were rabbit anti-human hNTCP polyclonal antibody (Sigma: HPA042727) and mouse anti-human GAPDH monoclonal antibody (Proteintech TM , Chicago, USA).
Immunofluorescence assay
An immunofluorescence assay was performed as described previously (Zhou et al., 2014b) . The primary antibodies were rabbit anti-HBcAg polyclonal antibody (Dako, Glostrup, Denmark), mouse anti-HBsAg monoclonal antibody (Cao L. et al., 2014) , mouse anti-CD81 antibody (Santa Cruz, California, USA), and rabbit antihNTCP polyclonal antibody (Sigma: HPA042727). The secondary antibodies were Alexa Fluor-488 or Alexa Fluor-568 conjugated (Life Technologies, Waltham, Massachusetts, USA). The nucleus was stained with DAPI (Roche, Basel, Switzerland). The stained cells were examined under a fluorescence microscope (Leica, Wetzlar, Germany) or confocal microscope (PerkinElmer, Massachusetts, USA).
Southern blot and Northern blot
HBV total DNA was extracted by a method described by Hirt (Hirt, 1967) , and core-associated HBV DNA was extracted by a method described elsewhere (Wu et al., 2010) . Southern blot was performed as described previously www.virosin.org DECEMBER 2017 VOLUME 32 ISSUE 6 467 (Zhou et al., 2014a) . Northern blot was performed as described elsewhere 
RESULTS
Resistance to DMSO and PEG8000
To obtain a Huh7 cell line tolerant to a high concentration of DMSO, we screened four Huh7 cell lines originated from different preservers. On day 4 post-2.5% DMSO treatment, all Huh7 cell lines proliferated to a confluent monolayer, but only the No.1 Huh7 cell line began to show a morphologically polarized character (Supplementary Figure S1 ). On day 8 post-DMSO treatment, only the No.1 Huh7 line grew well and further developed polarization, whereas the others nearly died out. The changes in cell viability were further confirmed using a CCK8 assay ( Figure 1A ). To discriminate it from the other three Huh7 cell lines, the No.1 Huh7 line was named Huh7D. Normally, 4% PEG8000 is added to the incubation medium during infection to enhance HBV attachment (Gripon et al., 1993) ; thus, resistance to 4% PEG8000 was another prerequisite for the cell line to ensure productive HBV infection. Therefore, this aspect of Huh7D cells was tested and further confirmed by comparison with HepG2 cells, the platform for an existing HBV infection cell model (HepG2 hNTCP ) (Yan et al., 2012; Ni et al., 2014) . As shown in Figure 1B , there were no significant differences between the presence and absence of PEG8000 for all time points except the first day, indicating that Huh7D cells were tolerant to 4% PEG8000. By comparison, the ratio of cell viabilities of Huh7D cells in the presence of PEG8000 was significantly higher than that of HepG2 cells at the indicated time points, implying that Huh7D cells had better resistance to PEG8000 than HepG2 cells ( Figure 1C ). Thus, Huh7D cells, which were resistant to 2.5% DMSO / 4% PEG8000, were used to establish an hNTCP-expressing cell model. Huh7D cells were cultured in the presence or absence of 4% PEG8000 for the indicated times, and cell viabilities were measured with ELISA by using CCK8. (C) Huh7D and HepG2 cells were maintained in the presence or absence of 4% PEG8000 for the indicated times. Cell viabilities were measured with ELISA by using CCK8. Data are presented as the ratio of viability in the presence of PEG8000 (+PEG) to viability in the absence of PEG8000 (-PEG). Differences were judged to be statistically significant when P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***).
Productive HBV infection of well-differentiated Huh7D hNTCP
Establishment of Huh7D hNTCP cells stably expressing hNTCP
In view of the high infection and integration rate of lentiviruses (Wiznerowicz and Trono, 2003) , hNTCPexpressing recombinant lentivirus were produced to efficiently achieve stable hNTCP expression. The hNTCPexpressing pWPI-hNTCP-Puro vector (Figure 2A ) was constructed and co-transfected with packaging plasmids (pCMV-dR8.91 and pMD.2G) into the 293T cell line to produce the hNTCP-expressing recombinant lentivirus. The relative mRNA level of hNTCP in Huh7D hNTCP cells was comparable to that in normal human liver tissue but significantly higher than that in Huh7D, HepG2 and HepG2 hNTCP cells, a HepG2 cell line that stably expresses hNTCP ( Figure 2B ). Smearing bands from 55 kDa to 72 kDa corresponding to hNTCP with varied degrees of Nglycosylation could be detected in Huh7D hNTCP cells, which was further validated by the observation that only one 38 kDa band corresponding to nonglycosylated hNTCP could be detected after PNGase F digestion ( Figure 2C ). Accordingly, the relative protein level of hNTCP in Huh7D hNTCP cells was also comparable to that in normal human liver tissue, whereas the hNTCP level was significantly lower in HepG2 hNTCP cells and undetectable in both Huh7D and HepG2 cells ( Figure 2D ). The immunofluorescence (IF) staining results showed that hNTCP was mainly located at the cell membrane of Huh7D hNTCP and HepG2 hNTCP cells ( Figure 2E ).
Huh7D hNTCP cells became well differentiated under DMSO treatment
To determine whether Huh7D hNTCP cells could become well differentiated under DMSO treatment, morphological changes, cell cycle progression, and expression of differentiation-associated genes were evaluated. Huh7D hNTCP cells started to undergo progressive morphological changes under DMSO treatment. On day 3 post-DMSO treatment, Huh7D hNTCP cells were induced to form polygonal cells. On day 15 post-DMSO treatment, the morphology of Huh7D hNTCP cells resembled that of PHHs, as both contained a centrally located nucleus, prominent nucleolus, and granular cytoplasm ( Figure 3A) . The flow cytometry results showed that 83.4%, 2.4%, and 11.6% of Huh7D hNTCP cells were in G0/G1 phase, S phase, and G1/G2 phase, respectively, after applying DMSO for 6 d, whereas approximately 51.6%, 22.6%, and 19.1% of cells without DMSO treatment were in G0/G1, S, and G1/G2 phase, respectively ( Figure 3B ). The transcription of differentiation-associated genes was examined, such as albumin, α-fetoprotein (AFP), hepatocyte nuclear factor 4α (HNF4α), human cytochrome P450 3A4 (CYP3A4), and asialoglycoprotein receptor (ASGPR). The representative genes positively associated with differentiation (albumin, HNF4a, CYP3A4, and ASGPR) were up-regulated, whereas the gene negatively associated with differentiation (AFP) was down-regulated ( Figure 3C ). Thus, Huh7D hNTCP cell could be induced into non-dividing, well-differentiated polarized cells under 2.5% DMSO treatment. Figure 4D ). At 1000 MOI, HBeAg and HBsAg levels in the supernatant of infected Huh7D hNTCP cells were both significantly higher than those in HepG2 hNTCP cells, whereas the entry inhibitor Myrcludex B blocked the infection, proving reliable entry specificity ( Figure 4D-4F) . At 7 dpi, significant HBV replicating intermediates could be detected in Huh7D hNTCP cells, whereas very weak signals corresponding to viral DNA was observed in HepG2 hNTCP cells ( Figure 4G ). Significantly more HBV transcripts, especially the 3.5 kb RNA, were observed in Huh7D hNTCP cells than in HepG2 hNTCP cells ( Figure 4H ). IF staining also revealed that approximately 25% of Huh7D hNTCP cells were HBcAg positive, whereas only 5% of HepG2 hNTCP cells were HBcAg positive ( Figure 4I ). These data indicated that Huh7D hNTCP cells were a productive cell model for HBV infection.
Infection of Huh7D hNTCP cells by HBV
Considering that Huh7D hNTCP cells expressed higher levels of hNTCP than HepG2 hNTCP cells ( Figure 2B, 2D ), we next determined whether HBV binding and/or uptake differed between these two cell lines. When incubated at 4 °C, more HBV was absorbed by Huh7D hNTCP cells than by HepG2 hNTCP cells ( Figure 4J ). When incubated at 37 °C followed by trypsin treatment, a positive signal could be detected in Figure S2) in accordance with the fact that Huh7 cells are fully permissive while HepG2 cells are resistant to HCV infection (Sainz and Chisari, 2006; Mee et al., 2009 ). Thus, these results indicated that Huh7D hNTCP cells are appropriate for use to investigate the co-infection of HBV and HCV.
DISCUSSION
It has been well documented that cell polarization and differentiation are crucial for HBV entry and HBV transcription (Gripon et al., 2002; Schulze et al., 2012) . For example, PHHs, the native host for HBV infection, rapidly dedifferentiate and lose susceptibility to HBV infection after being isolated and seeded (Zhou et al., 2014a) . DMSO treatment can maintain PHH differentiation and susceptibility to HBV infection. Some poorly differentiated human hepatoma derived cell lines such as HepaRG cells can be induced and differentiated into hepatocyte-like cells by DMSO (Gripon et al., 2002) . Moreover, DMSO treatment may directly favor HBV transcription and replication (Gripon et al., 1988; Gripon et al., 2002; Schulze-Bergkamen et al., 2003) . The expression of hNTCP can also be induced and maintained at a relatively high level by DMSO treatment (Ni encoding hNTCP was constructed, and the recombinant lentivirus was produced. hNTCP-expressing Huh7D cells were established by lentivirus transduction followed by puromycin screening. (B) Different cell lines were subjected to RTqPCR to detect relative hNTCP mRNA levels. (C) Cell lysates of Huh7D hNTCP cells were incubated at 37 °C for 1 h in the presence or absence of PNGase F, followed by western blot. (D) Different cell lines were subjected to western blot to detect the relative hNTCP protein levels. The relative protein levels (both glycosylated and non-glycosylated) are depicted as the relative integrated density (Rel. Den.). (E) Different cell lines were seeded at the same density and fixed for immunofluorescence analysis with the indicated antibodies using confocal microscopy, with green for hNTCP and blue for the nucleus. LTR: long tendon repeat; EF-1α: human elongation factor-1α promoter; IRES: internal ribosome entry site; Puro: puromycin-resistance gene.
Productive HBV infection of well-differentiated Huh7D hNTCP et al., 2014). Therefore, the addition of DMSO at different levels helps to improve HBV infection efficiency. However, high concentrations of DMSO are cytotoxic to hepatocytes (Sumida et al., 2011) and thus interfere with viral infection. In the present study, a Huh7 cell line named Huh7D was found to be tolerant to 2.5% DMSO and to fully differentiate into PHH-like cells under DMSO treatment, which may be the foundation of the successful establishment of productive HBV infection in the Huh7D hNTCP cell line. Figure 4D-4I) . This difference in HBV susceptibility was not likely caused by DMSO cytotoxicity because both cell lines were tolerant to 2.5% DMSO (data not shown). Given that Huh7D hNTCP cells expressed more hNTCP than HepG2 hNTCP cells ( Figure 2B, 2D) , we then compared the difference in viral adsorption and entry between these two cell lines. The results showed that Huh7D hNTCP cells exhibited more HBV binding and/or uptake ( Figure 4I ), which may partially explain the different infectivity levels between these two cell lines. In addition, although both Huh7 and HepG2 cells are hepatoma cell lines, they have distinct expression profiles of genes in various categories (Kawai et al., 2001) . Some unknown co-receptors or co-factors besides hNCTP, as well as DMSO-induced factors, necessary for productive HBV infection may be present at different levels in these two cell lines, which may be responsible for the differences in viral entry. Moreover, differences in viral transcription and replication caused by different liver-enriched genes cannot be completely ruled out.
In 2014 (Ni et al., 2014 (Schaefer, 2007) and different mutants, which may cause varying degrees of clinical viral hepatitis. It is possible that other HBV strains, e.g., other genotypes and/or HBeAg-negative isolates, could behave differently in terms of viral protein expression and infectivity, which need to be further studied. Nevertheless, the establishment of the Huh7D hNTCP cell line as another option will give virologists an alternative cell model to study HBV entry and develop novel antiviral agents. 
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The authors declare that they have no conflict of interest. Additional informed consent was obtained from all participating family members, who donated human materials. Ethical approval for the study was granted by = 2×10 3 ) for 24 h, and media were collected at 3, 5, 7, 9, and 11 dpi for detection of HBeAg (A) and HBsAg (B) by ELISA. Values over the cutoff line were regarded as positive. (C) Cells at 11 dpi were fixed to detect intracellular HBcAg (green) and HBsAg (red) by IF. Huh7D hNTCP and HepG2 hNTCP cells were maintained in 2.5% DMSO for 24 h and infected by HBV at the indicated MOI for 24 h in the presence of 4% PEG8000. (D) HBeAg in the culture medium (11 dpi) was measured by ELISA. To allow the detection of other hallmarks of HBV infection, further experiments were performed at a MOI of 1000 with Myrcludex B (MyrB, 500 nmol/L), which served as a control for infection specificity. Supernatants were collected at the indicated time points for the measurement of HBeAg (E) and HBsAg (F) by ELISA. (G) Intracellular HBV replicating intermediates were extracted from 2 × 10 6 infected cells at 7 dpi and detected by Southern blot, and the protein level of GAPDH was served as an internal control. (H) Approximately 30 μg total RNA was subjected to northern blot, and 28S/18S served as an internal control. (I) Cells at 11 dpi were fixed to detect intracellular HBcAg (green) and nuclear (blue) by IF. (J) Assay of binding and/or uptake was performed using 2 × 10 6 cells, which were incubated with the same MOI at 4 °C (HBV binding only), 37 °C (binding and uptake), or 37 °C but digested with trypsin for 10 min (uptake only). MyrB (500 nmol/L) was applied to block HBV entry. 
